Drugs / Tetanus, Diphtheria, and Pertussis Vaccine
Tetanus, Diphtheria, and Pertussis Vaccine
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT02783170 | Sep 2016 → Apr 2018 | pregnancy disorder | Duke University | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Tetanus, Diphtheria, and Pertussis Vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02783170 ↗ |
| Modality | Vaccine | “Tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine adsorbed (Tdap)” NCT02783170 ↗ |
| Route | Intramuscular | “single intramuscular (IM) 0.5 mL dose” NCT02783170 ↗ |